Unlock the power of UPNEEQ®, the sole FDA-approved prescription eyedrop designed to address acquired blepharoptosis (droopy, low-lying eyelids caused by aging, false lashes, etc) in adults. It works by targeting the muscle in the upper eye lid that results in the eyes to open wider. The results is a younger, refreshed-looking eye. Results can be seen in as little as 15 minutes and can last for up to 8 hours. Elevate your upper eyelids effortlessly, revealing eyes that captivate.
Upneeq (oxymetazoline hydrochloride ophthalmic solution), 0.1% is a prescription eyedrop used to treat acquired blepharoptosis (low-lying lids) in adults.
What is acquired ptosis(low-lying lids)?
Are low-lying eyelids making your eyes look a little tired? You may have acquired ptosis. This condition usually occurs when the muscles in the eyelid stretch and weaken, causing the upper eyelid to droop.
How does acquired acquired ptosis affect you?
Low-lying eyelid(s) can affect eyesight by not only blocking your vision, but also by reducing field of vision, which may interfere with day-to-day functions such as: reading, driving, computer use, and looking up without the need to tilt your head back.
What are the most common side effects of Upneeq?
The most common adverse reactions with UPNEEQ (occurring in 1-5% of patients) were eye inflammation, eye redness, dry eye, blurred vision, eye pain at time of use, eye irritation, and headache.